Experience of using adalimumab in treating sight-threatening paediatric or adolescent Behcet’s disease-related uveitis

PURPOSE: To report the clinical outcomes of adalimumab in treating refractory Behcet’s disease (BD)-related uveitis in paediatric or adolescent patients. METHODS: Retrospective review of five paediatric or adolescent patients with BD-related uveitis with a minimum follow-up of 24 months. RESULTS: Di...

Descripción completa

Detalles Bibliográficos
Autores principales: Ho, Mary, Chen, Li Jia, Sin, Helena P. Y., Iu, Lawrence P. L., Brelen, Marten, Ho, Assunta C. H., Lai, Timothy Y. Y., Young, Alvin L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2019
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6669227/
https://www.ncbi.nlm.nih.gov/pubmed/31367810
http://dx.doi.org/10.1186/s12348-019-0181-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6669227/
https://www.ncbi.nlm.nih.gov/pubmed/31367810
http://dx.doi.org/10.1186/s12348-019-0181-z

Ejemplares similares